Fig. 1From: Identification of a RAD51B enhancer variant for susceptibility and progression to gliomaSubgroup analyses for rs6573816 based on sex, age, WHO grade, and IDH mutation status in a dominant model. Central black dots indicate ORs. Horizontal lines represent 95% CIsBack to article page